Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits

Condition:   Proliferative Glomerulonephritis With Monoclonal IgG Deposits Intervention:   Drug: Daratumumab Sponsor:   Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials